State of Wisconsin Investment Board
CBIO

State of Wisconsin Investment Board’s Crescent Biopharma CBIO Stock Holding History

State of Wisconsin Investment Board’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-465
Closed -$554K – 1555
2019
Q2 		$554K Buy
465
+10
+2% +$12K ﹤0.01% 1296
2019
Q1 		$567K Buy
455
+105
+30% +$120K ﹤0.01% 1314
2018
Q4 		$331K Buy
350
+34
+11% +$40.9K ﹤0.01% 1405
2018
Q3 		$455K Hold
316
– – ﹤0.01% 1416
2018
Q2 		$510K Buy
+316
New +$543K ﹤0.01% 1363

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State of Wisconsin Investment Board's CBIO Position: Q3 2019 in Review

State of Wisconsin Investment Board sold out of Crescent Biopharma (CBIO) in Q3 2019, closing a stake of 465 shares — an estimated $554K sold.

State of Wisconsin Investment Board first reported a position in CBIO in Q2 2018 and held it in 5 quarters. The position peaked at $567K in Q1 2019. 75 funds tracked by Wall St. Rank hold CBIO as of Q3 2019.

  • State of Wisconsin Investment Board reported no remaining Crescent Biopharma position as of Q3 2019 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 465 Crescent Biopharma shares in Q3 2019, an estimated $554K.
  • State of Wisconsin Investment Board first reported a position in Crescent Biopharma in Q2 2018 and held it in 5 quarters.
  • State of Wisconsin Investment Board's Crescent Biopharma position peaked at $567K in Q1 2019.
  • 75 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2019, filed 12 Nov 2019.